We are live on ! Find out more
MED icon

Medifast

140 hedge funds and large institutions have $315M invested in Medifast in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more call options, than puts

Call options by funds: $4.18M | Put options by funds: $2.4M

22% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 45

8% more capital invested

Capital invested by funds: $292M → $315M (+$23.9M)

2.74% more ownership

Funds ownership: 81.97%84.71% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 144140 (-4)

17% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 23

Holders
140
Holders Change
-4
Holders Change %
-2.78%
% of All Funds
4.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
55
Reduced
45
Closed
23
Calls
$4.18M
Puts
$2.4M
Net Calls
+$1.78M
Net Calls Change
+$3.75M
Name Holding Trade Value Shares
Change
Change in
Stake
VAM
1
Visium Asset Management
New York
$36.3M +$2.67M +100,000 +8%
TSW
2
Thompson Siegel & Walmsley
Virginia
$20.3M -$622K -23,256 -3%
BFA
3
BlackRock Fund Advisors
California
$19.8M +$2.32M +86,665 +13%
Vanguard Group
4
Vanguard Group
Pennsylvania
$14.3M +$255K +9,545 +2%
Prudential Financial
5
Prudential Financial
New Jersey
$12.8M -$20.1K -750 -0.2%
GOFM
6
GGC Opportunity Fund Management
California
$12M +$1.53M +57,264 +15%
BIT
7
BlackRock Institutional Trust
California
$11.7M -$788K -29,464 -6%
Renaissance Technologies
8
Renaissance Technologies
New York
$10.2M +$580K +21,700 +6%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$9.38M +$485K +18,132 +5%
CCA
10
Conestoga Capital Advisors
Pennsylvania
$8.98M +$41.3K +1,545 +0.5%
Millennium Management
11
Millennium Management
New York
$8.95M +$4.08M +152,377 +84%
State Street
12
State Street
Massachusetts
$8.41M +$422K +15,763 +5%
KCM
13
Kennedy Capital Management
Missouri
$7.66M -$3.26M -121,963 -30%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$7.35M +$22.6K +846 +0.3%
OAM
15
Oxford Asset Management
United Kingdom
$6.37M +$4.45M +166,391 +236%
TA
16
Teachers Advisors
New York
$5.97M +$53.1K +1,985 +0.9%
BGIM
17
Brandywine Global Investment Management
Pennsylvania
$5.94M +$5.91M +220,875 New
Northern Trust
18
Northern Trust
Illinois
$5.25M +$329K +12,308 +7%
PCM
19
Portolan Capital Management
Massachusetts
$4.95M +$2.52M +94,168 +105%
PAMP
20
Polar Asset Management Partners
Ontario, Canada
$4.75M +$4.73M +176,800 New
American Century Companies
21
American Century Companies
Missouri
$4.6M +$362K +13,518 +9%
RFC
22
Russell Frank Company
Washington
$4.53M +$712K +26,612 +19%
RA
23
Royce & Associates
New York
$4.52M +$348K +13,000 +8%
AQR Capital Management
24
AQR Capital Management
Connecticut
$4.15M -$809K -30,262 -16%
TCIM
25
TIAA CREF Investment Management
New York
$3.73M -$217K -8,123 -6%

MED Hedge Fund Activity: Q3 2013 in Review

140 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2013, worth a combined $315M — up 8.2% from $292M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MED and 19 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 55 added.

The largest buyer was Brandywine Global Investment Management, opening a new position worth an estimated $5.91M. The largest seller was AJO LP, exiting entirely with an estimated $3.81M sold.

  • 140 institutional investors held Medifast (MED) as of Q3 2013, down from 144 in Q2 2013.
  • Funds reported $315M of Medifast stock for Q3 2013, up 8.2% quarter-over-quarter.
  • 19 funds opened new Medifast positions in Q3 2013 and 23 closed out, a net change of -4 holders.
  • The largest Medifast buyer in Q3 2013 was Brandywine Global Investment Management, an estimated $5.91M added.
  • The largest Medifast seller in Q3 2013 was AJO LP, an estimated $3.81M sold.

Based on aggregated 13F filings for Q3 2013.